SE436877B - Sett att framstella laktonderivat av cyklopentanol - Google Patents

Sett att framstella laktonderivat av cyklopentanol

Info

Publication number
SE436877B
SE436877B SE7702908A SE7702908A SE436877B SE 436877 B SE436877 B SE 436877B SE 7702908 A SE7702908 A SE 7702908A SE 7702908 A SE7702908 A SE 7702908A SE 436877 B SE436877 B SE 436877B
Authority
SE
Sweden
Prior art keywords
hydroxy
group
formula
compound
compounds
Prior art date
Application number
SE7702908A
Other languages
English (en)
Swedish (sv)
Other versions
SE7702908L (sv
Inventor
J Buendia
M Vivat
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE7702908L publication Critical patent/SE7702908L/xx
Publication of SE436877B publication Critical patent/SE436877B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7702908A 1976-03-19 1977-03-15 Sett att framstella laktonderivat av cyklopentanol SE436877B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7608004A FR2344285A1 (fr) 1976-03-19 1976-03-19 Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
SE7702908L SE7702908L (sv) 1977-09-20
SE436877B true SE436877B (sv) 1985-01-28

Family

ID=9170682

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7702908A SE436877B (sv) 1976-03-19 1977-03-15 Sett att framstella laktonderivat av cyklopentanol

Country Status (20)

Country Link
JP (1) JPS52113956A (fr)
AT (1) AT357275B (fr)
AU (1) AU506760B2 (fr)
BE (1) BE852624A (fr)
CA (1) CA1094569A (fr)
CH (1) CH620688A5 (fr)
DE (1) DE2711950A1 (fr)
DK (1) DK119377A (fr)
ES (1) ES456999A1 (fr)
FR (1) FR2344285A1 (fr)
GB (1) GB1538717A (fr)
HU (1) HU178332B (fr)
IE (1) IE45124B1 (fr)
IL (1) IL51690A (fr)
LU (1) LU76976A1 (fr)
NL (1) NL7703056A (fr)
PT (1) PT66326B (fr)
SE (1) SE436877B (fr)
SU (2) SU749364A3 (fr)
ZA (1) ZA771654B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2439779A2 (fr) * 1976-03-19 1980-05-23 Roussel Uclaf Nouvelles lactones derivees du cyclopentanol, leur procede de preparation et leur application comme medicaments
FR2443466A1 (fr) * 1978-12-05 1980-07-04 Roussel Uclaf Nouvelles b-lactones derivees de l'acide 2-hydroxy cyclopentane carboxylique, leur procede de preparation et leur application comme medicaments
DE3722133A1 (de) * 1987-07-04 1989-01-12 Bayer Ag Azolyl-tetrahydropyran-derivate
EP1142886A1 (fr) * 2000-04-07 2001-10-10 Aventis Pharma Deutschland GmbH Percyquinine, procédé pour sa production et son utilisation comme produit pharmaceutique
CN100417650C (zh) * 2006-08-17 2008-09-10 中国科学院昆明植物研究所 韧革菌素及其制备方法和在药物上的应用
WO2011013651A1 (fr) * 2009-07-28 2011-02-03 小野薬品工業株式会社 Composé bicyclique et utilisation de celui-ci à des fins médicales

Also Published As

Publication number Publication date
SE7702908L (sv) 1977-09-20
AT357275B (de) 1980-06-25
IL51690A0 (en) 1977-05-31
AU2346677A (en) 1978-09-28
BE852624A (fr) 1977-09-19
DE2711950A1 (de) 1977-09-29
IL51690A (en) 1982-02-28
GB1538717A (en) 1979-01-24
AU506760B2 (en) 1980-01-24
ZA771654B (en) 1978-04-26
FR2344285A1 (fr) 1977-10-14
IE45124L (en) 1977-09-19
ES456999A1 (es) 1978-01-16
HU178332B (en) 1982-04-28
PT66326B (pt) 1979-01-18
FR2344285B1 (fr) 1979-02-02
ATA195077A (de) 1979-11-15
SU745366A3 (ru) 1980-06-30
JPS52113956A (en) 1977-09-24
LU76976A1 (fr) 1977-10-03
IE45124B1 (en) 1982-06-30
JPS62146B2 (fr) 1987-01-06
DK119377A (da) 1977-09-20
CA1094569A (fr) 1981-01-27
CH620688A5 (en) 1980-12-15
PT66326A (fr) 1977-04-01
SU749364A3 (ru) 1980-07-15
NL7703056A (nl) 1977-09-21

Similar Documents

Publication Publication Date Title
Nicolaou et al. Synthesis of zaragozic acid A/squalestatin S1
US3822254A (en) Synthesis of 25-hydroxycholesterol
Bock et al. Preparation of 3-deoxyaldonolactones by hydrogenolysis of acetylated aldonolactones
US4545938A (en) Chemical synthesis
US3993675A (en) Process for the preparation of 1α,25-dihydroxycholecalciferol
Green et al. Synthesis of steroidal 16, 17-fused unsaturated. delta.-lactones
SE436877B (sv) Sett att framstella laktonderivat av cyklopentanol
Schaaf et al. Total synthesis of prostaglandins F1. alpha. and E1
Grieco et al. Pseudoguaianolides. 2. Stereocontrolled total synthesis of the helenanolide dl-helenalin
DE2319017B2 (de) Verfahren zur Herstellung von Prostaglandinen der Eins-Reihe
Salo et al. N-Acylenamines from oxazolines. New route to 2-acetamidogylcals
Kinsella et al. Approaches to the total synthesis of the antitumor antibiotic echinosporin
US3312717A (en) 3-oxygenated-13beta-alkyl-16-oxagona-1, 3, 5(10)-trien-17-ones, d-homo compounds corresponding, derivatives thereof, and intermediates thereto
US3342813A (en) Process for the preparation of butenolides derived from cyclopentano perhydro phenanthrenes
JPS6317077B2 (fr)
JPH06122653A (ja) 飽和単環炭化水素化合物の製造方法およびその中間体
US4221809A (en) β-Lactones of 2-hydroxy-cyclopentanecarboxylic acid
US3868413A (en) 2-(4-Hydroxy-1-alkynyl)-5-oxocyclopent-1-enealkanoic acids, 3-hydroxy congeners corresponding and derivatives thereof
KR810001170B1 (ko) 시클로펜탄올의 락톤 유도체의 제조 방법
US4535179A (en) Synthesis of bicyclic and tricyclic 7-oxa prostaglandin endoperoxide analogs via oxypalladation of norbornadiene
US3865833A (en) 1,3-diethers of 2-azaestratrienes and intermediates
SU439973A1 (ru) Способ получени производного метил-19-норпрогестерона
US3975412A (en) Mono-acylation of 17-hydroxy-3-alkoxygona-2,5-(10)dienes
US4279919A (en) Novel lactones of cyclopentanols
US2949472A (en) 1-carboalkoxymethyl-2-acetonyl-2, 4b-dimethyl-4-keto-1, 2, 3, 4, 4a, 4b, 5, 6, 7, 8,10, 10a-dodecahydrophenanthrene 7-ketals and processes of preparing them

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7702908-0

Effective date: 19900125

Format of ref document f/p: F